Orgenesis (STU:45O) Payments of Debt : €-2.83 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Payments of Debt?

Orgenesis's Payments of Debt for the three months ended in Dec. 2023 was €-0.00 Mil.

Orgenesis's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.83 Mil.

Orgenesis Payments of Debt Historical Data

The historical data trend for Orgenesis's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Payments of Debt Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Payments of Debt

Get a 7-Day Free Trial

-0.70

-2.35

-0.90

-2.22

-2.78

Orgenesis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Payments of Debt	Get a 7-Day Free Trial															-0.03	-2.82	-0.01	-	-

Orgenesis Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.83 Mil.

Orgenesis Payments of Debt Related Terms

Thank you for viewing the detailed overview of Orgenesis's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis (STU:45O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (STU:45O) » Definitions » Payments of Debt

Comparable Companies

Traded in Other Exchanges

ORGS:USA 45O:Germany

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (STU:45O) Headlines

No Headlines